Investing.com - Applied Genetic reported on Thursday first quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Applied Genetic announced earnings per share of $-0.360 on revenue of $325.0K. Analysts polled by Investing.com EPS of $-0.334 on revenue of $0.00.
Applied Genetic 's are down 67.82% and is trading at $0.290 , still down 90.91% from its 52 week high of $3.19 set on Wednesday, September 29, 2021.
Applied Genetic follows other major Healthcare sector earnings this month
Applied Genetic's report follows an earnings beat by Merck ADR on Friday, September 9, 2022, who reported EPS of $0.5392 on revenue of $5.69B, EPS of $0.5165 on revenue of $5.57B.
Veeva Systems A had beat expectations on Wednesday, August 31, 2022 with second quarter EPS of $1.03 on revenue of $534.22M, for EPS of $1.01 on revenue of $530.71M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar